Magdalene K Montgomery

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

High Fat Diet Induced

Hydrogen Peroxide

Top Venues

American journal of physiology. Endocrinology and metabolism

Science translational medicine

Nature communications

The FEBS journal

This page only lists publications with an associated author ORCID identifier.

Publications

Camille J Devereux, Jacqueline Bayliss, Stacey N Keenan, Magdalene K Montgomery, Matthew J Watt
Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice. American journal of physiology. Endocrinology and metabolism 324 (2) (2023)
Jie Lu, Li Dong, Magdalene K Montgomery
The GR-KLF15 axis promotes suppression of hepatic lipogenesis during fasting. The FEBS journal (2023)
Camille J Devereux, Jacqueline Bayliss, Stacey N Keenan, Magdalene K Montgomery, Matthew J Watt
Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice. American journal of physiology. Endocrinology and metabolism 324 (2) (2023)
Camille J Devereux, Jacqueline Bayliss, Stacey N Keenan, Magdalene K Montgomery, Matthew J Watt
Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice. American journal of physiology. Endocrinology and metabolism 324 (2) (2023)
Camille J Devereux, Jacqueline Bayliss, Stacey N Keenan, Magdalene K Montgomery, Matthew J Watt
Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice. American journal of physiology. Endocrinology and metabolism 324 (2) (2023)
Magdalene K Montgomery, Jacqueline Bayliss, Shuai Nie, William De Nardo, Stacey N Keenan, Paula M Miotto, Hamzeh Karimkhanloo, Cheng Huang, Ralf Bernd Schittenhelm, Anthony S Don, Andrew Ryan, Nicholas A Williamson, Geraldine J Ooi, Wendy A Brown, Paul R Burton, Benjamin L Parker, Matthew J Watt
Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control. Nature communications 13 (1) (2022)
Magdalene K Montgomery, Jacqueline Bayliss, Camille J Devereux, Ayenachew Bezawork-Geleta, David Roberts, Cheng Huang, Ralf Bernd Schittenhelm, Andrew Ryan, Scott L Townley, Luke A Selth, Trevor J Biden, Gregory R Steinberg, Dorit Samocha-Bonet, Ruth C R Meex, Matthew J Watt
SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control. Science translational medicine 12 (559) (2021)